[CD47/SIRPa Summit 2020] A Novel MOA-reflective Bioassay for Quantifying Potency of Therapeutics Targeting the SIRPα|CD47 Signaling Axis
- File Name/Number:
- CD47/SIRPa Summit 2020
- Year:
- 2020
Watch Recorded Presentation
Jane Lamerdin, Ph.D.
Director R&D, Eurofins DiscoverX